Diagnosis of vascular cognitive impairment and its main categories;Diagnóstico del deterioro cognitivo vascular y sus principales categorías

Neurologia

Volumn 30, Issue 4, 2015, Pages 223-239

  Rodriguez Garcia P L ^a   Rodriguez Garcia D ^a  

^a Hospital General Docente Dr Ernesto Guevara de la Serna   (Cuba)

Author keywords

Cerebrovascular diseases; Mild cognitive impairment; Post stroke dementia; Stroke; Vascular dementia

Indexed keywords

ALZHEIMER DISEASE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DISEASE CLASSIFICATION; HUMAN; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; SHORT SURVEY; BRAIN; CEREBROVASCULAR ACCIDENT; CLASSIFICATION; COMPLICATION; DEMENTIA, VASCULAR; DIFFERENTIAL DIAGNOSIS; PATHOLOGY;

ALZHEIMER DISEASE; BRAIN; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; HUMANS; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; STROKE;

EID: 84928209072     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2011.12.014     Document Type: Short Survey

References (118)

1. Hachinski V., Iadecola C., Petersen R.C., Breteler M.M., Nyenhuis D.L., Black S.E., et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006, 37:2220-2241.
2. Kalaria R.N., Maestre G.E., Arizaga R., Friedland R.P., Galasko D., Hall K., et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008, 7:812-826.
3. Iemolo F., Duro G., Rizzo C., Castiglia L., Hachinski V., Caruso C. Pathophysiology of vascular dementia. Immun Ageing 2009, 6:13.
4. Leys D., Hénon H., Mackowiak-Cordoliani M., Pasquier F. Poststroke dementia. Lancet Neurol 2005, 4:752-759.
5. Moorhouse P., Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008, 7:246-255.
6. Aggarwal N.T., DeCarli C. Vascular dementia: emerging trends. Semin Neurol 2007, 27:66-77.
7. Erkinjuntti T., Gauthier S. The concept of vascular cognitive impairment. Front Neurol Neurosci 2009, 24:79-85.
8. Robillard A. Clinical diagnosis of dementia. Alzheimers Dement 2007, 3:292-398.
9. Grinberg L., Heinsen H. Toward a pathological definition of vascular dementia. J Neurol Sci 2010, 299:136-138.
10. Villarejo A., Puertas-Martín A. Utilidad de los test breves en el cribado de demencia. Neurología 2011, 10.1016/j.nrl.2010.12.002.
11. Wiederkehr S., Simard M., Fortin C., van Reekum R. Comparability of the clinical diagnostic criteria for vascular dementia: a critical review. Part I. J Neuropsychiatry Clin Neurosci 2008, 20:150-161.
12. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., García J.H., et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260.
13. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington DC. 4th ed.
14. Bayona H. Demencia vascular: un reto para el clínico. Acta Neurol Colomb 2010, 26(Suppl(3:1)):69-77.
15. Chui H.C. Subcortical ischemic vascular dementia. Neurol Clin 2007, 25:717-740. vi.
16. Knopman D.S. Cerebrovascular disease and dementia. Br J Radiol 2007, 80:S121-S127.
17. Naik M., Nygaard H. Diagnosing dementia - ICD-10 not so bad after all: a comparison between dementia criteria according to DSM-IV and ICD-10. Int J Geriatr Psychiatry 2008, 23:279-282.
18. Nagata K., Saito H., Ueno T., Sato M., Nakase T., Maeda T., et al. Clinical diagnosis of vascular dementia. J Neurol Sci 2007, 257:44-48.
19. Bowler J.V. Vascular cognitive impairment. J Neurol Neurosurg Psychiatry 2005, 76(Suppl 5):v35-v44.
20. Hanson J.C., Lippa C.F. Lewy body dementia. Int Rev Neurobiol 2009, 84:215-228.
21. Arvanitakis Z. Update on frontotemporal dementia. Neurologist 2010, 16:16-22.
22. Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994, 5:130-132.
23. Desmond D.W. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit?. J Neurol Sci 2004, 226:3-7.
24. Schneck M. Vascular dementia. Top Stroke Rehabil 2008, 15:22-26.
25. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer Disease Diagnostic and Treatment Centers (ADDTC). Neurology 1992, 42:473-480.
26. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 2011, 7:263-269.
27. Albert M.S., Dekosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement 2011, 7:270-279.
28. Sánchez-Rodríguez J.L., Torrellas-Morales C. Revisión del constructo deterioro cognitivo leve: aspectos generales. Rev Neurol 2011, 52:300-305.
29. Petersen R.C. Mild cognitive impairment. N Engl J Med 2011, 364:2227-2234.
30. Robles A., del Ser T., Alom C., Peña-Casanova J. Propuesta de criterios para el diagnóstico clínico del deterioro cognitivo ligero, la demencia y la enfermedad de Alzheimer. Neurología 2002, 17:17-32. Grupo Asesor del Grupo de Neurología de la Conducta y Demencias de la Sociedad Española de Neurología.
31. Ropper A.H., Brown R.H. Adams and Victor's Principles of Neurology 2005, McGraw-Hill, New York, p 367-384. 8th ed.
32. Emre M. Classification and diagnosis of dementia: a mechanism-based approach. Eur J Neurol 2009, 16:168-173.
33. Rockwood K., Moorhouse P.K., Song X., MacKnight C., Gauthier S., Kertesz A., et al. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. J Neurol Sci 2007, 252:106-112.
34. Román G.C., Sachdev P., Royall D.R., Bullock R.A., Orgogozo J., López-Pousa S., et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004, 226:81-87.
35. Murray M.E., Knopman D.S., Dickson D.W. Vascular dementia: clinical, neuroradiologic and neuropathologic aspects. Panminerva Med 2007, 49:197-207.
36. Chui H.C., Brown N.N. Vascular cognitive impairment. CONTINUUM: Lifelong Learning in Neurology 2007, 13:109-143.
37. Jellinger K.A. Morphologic diagnosis of "vascular dementia"-a critical update. J Neurol Sci 2008, 270:1-12.
38. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research 1993, World Health Organization, World Health Organization, Geneva, p. 36-40.
39. Mast H., Tatemichi T.K., Mohr J.P. Chronic brain ischemia: the contributions of Otto Binswanger and Alois Alzheimer to the mechanisms of vascular dementia. J Neurol Sci 1995, 132:4-10.
40. Babikian V.L., Wolfe N., Linn R., Knoefel J.E., Albert M.L. Cognitive changes in patients with multiple cerebral infarcts. Stroke 1990, 21:1013-1018.
41. Pendlebury S.T., Rothwell P.M. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009, 8:1006-1018.
42. Hachinski V.C., Lassen N.A., Marshall J. Multi-infarct dementia: A cause of mental deterioration in the elderly. Lancet 1974, 304:207-209.
43. Meyer J.S., Rogers R.L., Judd B.W., Mortel K.F., Sims P. Cognition and cerebral blood flow fluctuate together in multi-infarct dementia. Stroke 1988, 19:163-169.
44. Hoffmann M., Schmitt F., Bromley E. Vascular cognitive syndromes: relation to stroke etiology and topography. Acta Neurol Scand 2009, 120:161-169.
45. Vallar G. Spatial neglect, Balint-Homes 'and Gerstmann's syndrome, and other spatial disorders. CNS Spectr 2007, 12:527-536.
46. Estévez-González A., García-Sánchez C., Barraquer-Bordas L. Los lóbulos frontales: el cerebro ejecutivo. Rev Neurol 2000, 31:566-577.
47. Piguet O., Bennett H.P., Waite L.M., Kril J.J., Creasey H., Anthony B.G., et al. Preserved cognition and functional independence after a large right posterior cerebral artery infarct: longitudinal clinical and neuropathological findings. Neurocase 2006, 12:81-90.
48. Bermejo P.E., Zabala J.A., Vaquero A. Demencia por infarto estratégico. Neurología 2008, 23:53-54.
49. Shim Y.S., Kim J.S., Shon Y.M., Chung Y.A., Ahn K.J., Yang D.W. A serial study of regional cerebral blood flow deficits in patients with left anterior thalamic infarction: anatomical and neuropsychological correlates. J Neurol Sci 2008, 266:84-91.
50. Nishio Y., Hashimoto M., Ishii K., Mori E. Neuroanatomy of a neurobehavioral disturbance in the left anterior thalamic infarction. J Neurol Neurosurg Psychiatry 2011, 10.1136/jnnp.2010.236463.
51. Lanna M.E., Madeira D.M., Alves G., Alves C.E., Valente L.E., Laks J., et al. Vascular dementia by thalamic strategic infarct. Arq Neuropsiquiatr 2008, 66:412-414.
52. Carlesimo G.A., Lombardi M.G., Caltagirone C. Vascular thalamic amnesia: a reappraisal. Neuropsychologia 2011, 49:777-789.
53. Schmahmann J.D. Vascular syndromes of the thalamus. Stroke 2003, 34:2264-2278.
54. Kim S.H., Park K.H., Sung Y.H., Lee Y.B., Park H.M., Shin D.J. Dementia mimicking a sudden cognitive and behavioral change induced by left globus pallidus infarction: review of two cases. J Neurol Sci 2008, 272:178-182.
55. Bokura H., Robinson R.G. Long-term cognitive impairment associated with caudate stroke. Stroke 1997, 28:970-975.
56. Chukwudelunzu F.E., Meschia J.F., Graff-Radford N.R., Lucas J.A. Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule. J Neurol Neurosurg Psychiatry 2001, 71:658-662.
57. Mizuta H., Motomura N. Memory dysfunction in caudate infarction caused by Heubner's recurring artery occlusion. Brain Cogn 2006, 61:133-138.
58. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010, 9:689-701.
59. Gerraty R.P., Parsons M.W., Barber P., Darby D., Davis S.M. The volume of lacunes. Stroke 2001, 32:1937-1938.
60. Staekenborg S.S., van der Flier W.M., van Straaten E.C., Lane R., Barkhof F., Scheltens P. Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke 2008, 39:317-322.
61. Zhang A.J., Yu X.J., Wang M. The clinical manifestations and pathophysiology of cerebral small vessel disease. Neurosci Bull 2010, 26:257-264.
62. Ramos-Estebanez C., Moral-Arce I., Gonzalez-Mandly A., Dhagubatti V., Gonzalez-Macias J., Muñoz R., et al. Vascular cognitive impairment in small vessel disease: clinical and neuropsychological features of lacunar state and Binswanger's disease. Age Ageing 2011, 40:175-180.
63. Zhou A., Jia J. Different cognitive profiles between mild cognitive impairment due to cerebral small vessel disease and mild cognitive impairment of Alzheimer's disease origin. J Int Neuropsychol Soc 2009, 15:898-905.
64. Gouw A.A., Seewann A., van der Flier W., Barkhof F., Rozemuller A., Scheltens P., et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011, 82:126-135.
65. Jiménez I., Agulla J., Pouso M., Sabucedo M., Rodríguez-Yáñez M., Sobrino T., et al. Deterioro cognitivo asociado a la leucoaraiosis: fisiopatología, manifestaciones clínicas y tratamiento. Rev Neurol 2008, 47:536-544.
66. O'Sullivan M. Leukoaraiosis. Pract Neurol 2008, 8:26-38.
67. Pantoni L. Leukoaraiosis: From an ancient term to an actual marker of poor prognosis. Stroke 2008, 39:1401-1403.
68. Smith E.E. Leukoaraiosis and stroke. Stroke 2010, 41:S139-S143.
69. Gorelick P.B., Bowler J.V. Advances in vascular cognitive impairment. Stroke 2010, 41:e93-e98.
70. Baezner H., Blahak C., Poggesi A., Pantoni L., Inzitari D., Chabriat H., et al. Association of gait and balance disorders with age-related white matter changes: The LADIS study. Neurology 2008, 70:935-942.
71. McMurtray A.M., Liao A., Haider J., Licht E., Mendez M.F. Cognitive performance after lacunar stroke correlates with leukoaraiosis severity. Cerebrovasc Dis 2007, 24:271-276.
72. Debette S., Bombois S., Bruandet A., Delbeuck X., Lepoittevin S., Delmaire C., Leys D., Pasquier F. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 2007, 38:2924-2930.
73. Tiehuis A.M., Vincken K.L., Mali W.P., Kappelle L.J., Anbeek P., Algra A., et al. Automated and visual scoring methods of cerebral white matter hyperintensities: relation with age and cognitive function. Cerebrovasc Dis 2008, 25:59-66.
74. Zhu Y., Dufouil C., Tzourio C., Chabriat H. Silent Brain Infarcts: A review of MRI diagnostic criteria. Stroke 2011, 42:1140-1145.
75. Jokinen H., Gouw A.A., Madureira S., Ylikoski R., van Straaten E.C., van der Flier W.M., et al. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011, 76:1872-1878.
76. Filley C., Brodtmann A. Lacunes and cognitive decline: little things matter [Editorial]. Neurology 2011, 76:1856-1857.
77. Benisty S., Gouw A.A., Porcher R., Madureira S., Hernandez K., Poggesi A., et al. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 2009, 80:478-483.
78. Koga H., Takashima Y., Murakawa R., Uchino A., Yuzuriha T., Yao H. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals. J Stroke Cerebrovasc Dis 2009, 18:32-37.
79. Vermeer S.E., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol 2007, 6:611-619.
80. Das R.R., Seshadri S., Beiser A.S., Kelly-Hayes M., Au R., Himali J.J., et al. Prevalence and correlates of silent cerebral infarcts in the Framingham Off spring study. Stroke 2008, 39:2929-2935.
81. Grau-Olivares M., Arboix A., Bartrés-Faz D., Junqué C. Neuropsychological abnormalities associated with lacunar infarction. J Neurol Sci 2007, 257:160-165.
82. Grau-Olivares M., Bartrés-Faz D., Arboix A., Soliva J.C., Rovira M., Targa C., et al. Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment. Cerebrovasc Dis 2007, 23:353-361.
83. Menon U., Kelley R.E. Subcortical ischemic cerebrovascular dementia. Int Rev Neurobiol 2009, 84:21-33.
84. Grau-Olivares M., Arboix A. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?. Expert Rev Neurother 2009, 9:1201-1217.
85. André C. CADASIL: pathogenesis, clinical and radiological findings and treatment. Arq Neuropsiquiatr 2010, 68:287-299.
86. del Río-Espínola A., Mendióroz M., Domingues-Montanari S., Pozo-Rosich P., Solé E., Fernández-Morales J., et al. CADASIL management or what to do when there is little one can do. Expert Rev Neurother 2009, 9:197-210.
87. Kuljic-Obradovic D., Labudovic G., Basurovic N., Savic M. Neuropsychological deficits after bithalamic hemorrhages. J Neurol Sci 2007, 257:174-176.
88. Seo S.W., Hwa L.B., Kim E.J., Chin J., Sun C.Y., Yoon U., et al. Clinical significance of microbleeds in subcortical vascular dementia. Stroke 2007, 38:1949-1951.
89. Battistin L., Cagnin A. Vascular cognitive disorder. A biological and clinical overview. Neurochem Res 2010, 35:1933-1938.
90. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 2010, 120:287-296.
91. Bastos-Leite A.J., van der Flier W.M., van Straaten E.C., Staekenborg S.S., Scheltens P., Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007, 38:3182-3185.
92. Gorelick P.B., Scuteri A., Black S.E., Decarli C., Greenberg S.M., Iadecola C., et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:2672-2713.
93. Rodríguez-García PL, Rodríguez-García D. Letter by Rodríguez-García and Rodríguez-García Regarding Article, Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011;42:e584.
94. Dong Y., Sharma V.K., Chan B.P., Venketasubramanian N., Teoh H.L., Seet R.C., et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci 2010, 299:15-18.
95. Zetterberg H., Mattsson N., Blennow K. Cerebrospinal fluid analysis should be considered in patients with cognitive problems. Int J Alzheimers Dis 2010, 163065.
96. Hesse C., Rosengren L., Andreasen N., Davidson P., Vanderstichele H., Vanmechelen E., et al. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 2001, 297:187-190.
97. Ost M., Nylén K., Csajbok L., Ohrfelt A.O., Tullberg M., Wikkelsö C., et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 2006, 67:1600-1604.
98. Sämgård K., Zetterberg H., Blennow K., Hansson O., Minthon L., Londos E. Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity. Int J Geriatr Psychiatry 2010, 25:403-410.
99. Wallin A., Blennow K., Rosengren L. Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype. Alzheimer Dis Assoc Disord 1999, 13:S102-S105.
100. Petzold A., Keir G., Warren J., Fox N., Rossor M.N. A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia. Neurodegener Dis 2007, 4:185-194.
101. Abdulle S., Mellgren A., Brew B.J., Cinque P., Hagberg L., Price R.W., et al. CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration. J Neurol 2007, 254:1026-1032.
102. Gisslen M., Hagberg L., Brew B.J., Cinque P., Price R.W., Rosengren L. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis 2007, 195:1774-1778.
103. Wallin A., Sjogren M. Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia. Mech Ageing Dev 2001, 122:1937-1949.
104. Tarkowski E., Tullberg M., Fredman P., Wikkelso C. Correlation between intrathecal sulfatide and TNF-alpha levels in patients with vascular dementia. Dement Geriatr Cogn Disord 2003, 15:207-211.
105. Bjerke M., Zetterberg H., Edman A., Blennow K., Wallin A., Andreasson U. Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in Vascular Dementia and Alzheimer's Disease. J Alzheimers Dis 2011, 26:1-12.
106. Di Carlo A., Lamassa M., Baldereschi M., Inzitari M., Scafato E., Farchi G., et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007, 68:1909-1916.
107. Narasimhalu K., Ang S., De Silva D.A., Wong M.C., Chang H.M., Chia K.S., et al. The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients. Stroke 2011, 42:883-888.
108. Stephan B.C., Matthews F.E., Khaw K.T., Dufouil C., Brayne C. Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimers Res Ther 2009, 1:4.
109. Reisberg B., Ferris S.H., Kluger A., Franssen E., Wegiel J., de Leon M.J. Mild cognitive impairment (MCI): a historical perspective. Int Psychogeriatr 2008, 20:18-31.
110. Nelson A.P., O'Connor M.G. Mild cognitive impairment: a neuropsychological perspective. CNS Spectr 2008, 13:56-64.
111. Forlenza O.V., Diniz B.S., Nunes P.V., Memória C.M., Yassuda M.S., Gattaz W.F. Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr 2009, 21:1088-1095.
112. Nordlund A., Rolstad S., Klang O., Edman A., Hansen S., Wallin A. Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study. J Neurol Neurosurg Psychiatry 2010, 81:541-546.
113. Mariani E., Monastero R., Mecocci P. Mild cognitive impairment: a systematic review. J Alzheimers Dis 2007, 12:23-35.
114. Staekenborg S.S., Koedam E.L., Henneman W.J., Stokman P., Barkhof F., Scheltens P., et al. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke 2009, 40:1269-1274.
115. Bombois S., Debette S., Bruandet A., Delbeuck X., Delmaire C., Leys D., et al. Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients. Stroke 2008, 39:2046-2051.
116. Smith E.E., Egorova S., Blacker D., Killiany R.J., Muzikansky A., Dickerson B.C., et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008, 65:94-100.
117. Jacobs H.I., Visser P.J., Van Boxtel M.P., Frisoni G.B., Tsolaki M., Papapostolou P., et al. The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging 2010, 10.1016/j.neurobiolaging.2010.07.015.
118. Gainotti G., Ferraccioli M., Vita M.G., Marra C. Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy. J Int Neuropsychol Soc 2008, 14:611-619.